Grants and IIT Program

The IIT program at Haemonetics supports original, independent, investigator-initiated research aimed at advancing science and clinical care. The company reviews unsolicited requests for research support, which may include devices, disposable, reagents, software and/or funding.

Areas of high research interest include, but are not limited to:

• Personalized treatment algorithms for high bleeding risk conditions, such as trauma, cardiovascular surgery, liver transplant, post-partum hemorrhage etc.
• Tailored thromboprophylaxis (i.e., antiplatelet and anticoagulant therapies) in cardiovascular patients (e.g., Coronary Artery Disease, Peripheral Artery Disease)
• Coagulation profiles and clinical outcomes in patient populations at increased risk for thrombotic complications (e.g., patients admitted to ICU)
• Clinical and health-economic benefits of device assisted vascular closure

Review Criteria

Decisions are based upon scientific merit, proposal’s clinical significance, feasibility and likelihood of success given the Principal Investigator’s track record and research environment, as well as alignment with Haemonetics’ areas of research interest and availability of resources.

Submission Process

Only full protocol submissions will be reviewed by the Scientific Review Committee. However, if you wish to gain insights regarding the company’s interest in your research idea, you can submit a concept form for review by the Medical Director.

The link to the Haemonetics investigator-initiated trial grant request form can be found here: https://Haemonetics.medcompli.com. Once you create a grant requester login using your email, then pick “Make a request” from the main page, and select “Haemonetics Investigator-initiated trial proposal” from the drop-down list.  If you have any questions about the form, or have questions you would like to ask before submitting a request, you can reach out to the Medical Affairs team at Haemoneticsgrantsprogram@haemonetics.com. 

To submit a protocol for consideration, please send the protocol (see instructions below) along with any supporting documentation via the “Haemonetics Investigator-initiated trial proposal” form process detailed above.

• CV or biosketch of the Principal Investigator
• Research Plan (in Arial, font size ≥ 11, 1 inch margin on all sides) consisting of: 
  • Introduction – Brief description of problem, hypotheses and aims (1/2 page max) 
  • Approach – Concise overview of the research methods including statistical analysis plan (2 pages max) 
  • Timeline and Budget – Can be in a chart format  (1/2 page max) 
  • References (no page limitation) 

If you wish to do so, please email the program administrator for a template.